The early events that initiate β-amyloid aggregation in Alzheimer's disease

X Zhang, Z Fu, L Meng, M He, Z Zhang - Frontiers in aging …, 2018 - frontiersin.org
Alzheimer's disease (AD) is characterized by the development of amyloid plaques and
neurofibrillary tangles (NFTs) consisting of aggregated β-amyloid (Aβ) and tau, respectively …

Early biomarkers of neurodegenerative and neurovascular disorders in diabetes

A Gasecka, D Siwik, M Gajewska… - Journal of Clinical …, 2020 - mdpi.com
Diabetes mellitus (DM) is a common disease worldwide. There is a strong association
between DM and neurovascular and neurodegenerative disorders. The first group mainly …

Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus

G M. Ashraf, N H. Greig, T A. Khan… - CNS & Neurological …, 2014 - benthamdirect.com
In general, proteins can only execute their various biological functions when they are
appropriately folded. Their amino acid sequence encodes the relevant information required …

Ion mobility spectrometry–mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors

LM Young, P Cao, DP Raleigh… - Journal of the …, 2014 - ACS Publications
The molecular mechanisms by which different proteins assemble into highly ordered fibrillar
deposits and cause disease remain topics of debate. Human amylin (also known as islet …

No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases

DB Kell, E Pretorius - Biological Reviews, 2018 - Wiley Online Library
Since the successful conquest of many acute, communicable (infectious) diseases through
the use of vaccines and antibiotics, the currently most prevalent diseases are chronic and …

[HTML][HTML] Pathophysiology of type 2 diabetes: the evolution of our understanding

S Brunton - J Fam Pract, 2016 - mdedge.com
Abstract Type 2 diabetes (T2D) is now understood to be a complex disorder that involves
multiple organ systems. However, in the early 1900s, scientists believed diabetes to be a …

IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo

A Venkatanarayan, P Raulji, W Norton, D Chakravarti… - Nature, 2015 - nature.com
TP53 is commonly altered in human cancer, and Tp53 reactivation suppresses tumours in
vivo in mice,(TP53 and Tp53 are also known as p53). This strategy has proven difficult to …

Inhibition of hIAPP amyloid aggregation and pancreatic β‐cell toxicity by OH‐terminated PAMAM dendrimer

EN Gurzov, B Wang, EH Pilkington, P Chen, A Kakinen… - Small, 2016 - Wiley Online Library
Human islet amyloid polypeptide (hIAPP, or amylin) forms amyloid deposits in the islets of
Langerhans, a phenomenon that is associated with type‐2 diabetes impacting millions of …

The place of dipeptidyl peptidase‐4 inhibitors in type 2 diabetes therapeutics: A “me too” or “the special one” antidiabetic class?

R Godinho, C Mega… - Journal of diabetes …, 2015 - Wiley Online Library
Incretin‐based therapies, the most recent therapeutic options for type 2 diabetes mellitus
(T2DM) management, can modify various elements of the disease, including hypersecretion …

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's …

H Zhu, X Wang, M Wallack, H Li, I Carreras… - Molecular …, 2015 - nature.com
Amylin, a pancreatic peptide, and amyloid-beta peptides (Aβ), a major component of
Alzheimer's disease (AD) brain, share similar β-sheet secondary structures, but it is not …